Computer-Aided Drug Design
- ADME/Tox Prediction
- De Novo Drug Design
- Ligand-Based Virtual Screening
- Quantum Mechanics
- Structure-Based Virtual Screening
- DNA-Encoded Library Technology
- Fragment-Based Screening
- High Content Screening
High Throughput Screening
- Assay Development
- Automated HTS Platform
- Biochemical Assays
- Bio-Layer Interferometry
- Circular Dichroism Spectroscopy
- Isothermal Titration Calorimetry
- Mass Spectrometry
- Microscale Thermophoresis
- Nuclear Magnetic Resonance Spectrometry
- Surface Plasmon Resonance Spectrometry
- Thermal Shift Assay
- Cellular Assays
- Compound Libraries
- Data Management
- Drug Repurposing
- Hit Screening
- Virtual Screening
- Experienced and qualified scientists functioning as project managers or study director
- Independent quality unit assuring regulatory compliance
- Methods validated per ICH GLP/GMP guidelines
- Rigorous sample tracking and handling procedures to prevent mistakes
- Controlled laboratory environment to prevent a whole new level of success
SVM for Lead DiscoveryINQUIRY
SVM has been explored as a ligand-based virtual screening (VS) tool for facilitating lead discovery. The goal of this method is to create a decision boundary that separates two classes of points according to the active and inactive compounds. A key characteristic of SVM is to reduce the error on training data, minimize the complexity of models and avoid the overfitting with the application of the structural risk minimization approach.
Easy to understand: Simple geometric interpretation.
Nonlinear decisions based on the use of kernels.
Application in Drug Discovery
SVM is applied to predict the distinction between active compounds and inactive ones through binary class labeling.
SVM can also be utilized to rank compounds in database according to their activity potential in virtual screening.
SVM can assess potency of candidates and theirs druggability.
We have established an advanced SVM platform to optimize the screening process using the maximum margin hyperplanes.
Our SVM technologies can separate the active from the inactive compounds rapidly and have the largest possible distance from any labeled compound.
We have experience in choosing right SVM parameters to develop SVM models.
Our teams apply the cross validation-derived statistic to select one among the different possible models.
We provide both single and multi-target prediction with high success rate.
At BOC Sciences, our professional scientists are capable of performing data processing and interpretation.
Xiao, H. M.; et al. In-Silico Approaches to Multi-target Drug Discovery. Pharm Res. 2010, 27(5): 739-749.
※ It should be noted that our service is only used for research.